← Browse by Condition
Medical Condition
urothelial cancer
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3
NCT06657157
Recruiting
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
Enrollment
80 pts
Location
Germany
Sponsor
Comprehensive Cancer Center Mu...
NCT06011954
Recruiting
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Enrollment
202 pts
Location
South Korea
Sponsor
Astellas Pharma Korea, Inc.
NCT04923178
Recruiting
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Enrollment
1,100 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07193511 Phase 1, Phase 2
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Enrollment
355 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
NCT04724018 Phase 1, Phase 2
Recruiting
Sacituzumab Govitecan Plus EV in Metastatic UC
Enrollment
106 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Enrollment
470 pts
Location
United States, Argen...
Sponsor
Bristol-Myers Squibb